ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD) financial statements, including revenue, expenses, profit, and loss
The total revenue of 0QNV for the last quarter is 58.35 k CHF, and it's 49.39% lower compared to the previous quarter. The net income of Q3 24 is -1.53 M CHF.